What is PANDA (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is PANDAS?

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) is a controversial clinical syndrome characterized by the sudden onset of obsessive-compulsive disorder (OCD) and/or tics following group A streptococcal infection, though the American Heart Association considers it "a yet-unproven hypothesis" that requires cautious interpretation. 1, 2, 3

Core Clinical Features

PANDAS presents with a distinctive constellation of symptoms that differentiate it from typical psychiatric conditions:

  • Abrupt onset of obsessive-compulsive symptoms and/or motor/vocal tics that are temporally related to streptococcal infection 3, 4
  • New choreiform movements (involuntary, irregular, dance-like movements) are key distinguishing features to assess 2
  • The sudden onset pattern contrasts sharply with classic OCD, which typically has gradual onset 3
  • Additional neuropsychiatric symptoms may include behavioral changes, anxiety, and emotional lability 4, 5

Proposed Pathophysiology

The underlying mechanism is thought to involve an aberrant autoimmune response:

  • Following group A beta-hemolytic streptococcal infection, antibodies may cross-react with neuronal tissue in the basal ganglia 6, 7
  • Neuropathological examination has shown CD4- and CD25-positive T cell infiltration in basal ganglia, suggesting neuroinflammation 7
  • The autoimmune hypothesis remains unproven despite these findings 1, 3

Diagnostic Approach

The American Heart Association explicitly recommends against routine laboratory testing for group A streptococcus solely to diagnose PANDAS 2, 3, but when clinical suspicion is high:

  • Obtain anti-streptolysin O (ASO) titer and anti-DNase B titer to document recent strep exposure, with ASO peaking 3-6 weeks post-infection and anti-DNase B peaking 6-8 weeks post-infection 2
  • Throat culture is indicated only if throat symptoms are present 2
  • Post-treatment throat cultures are indicated only in symptomatic patients, those with symptom recurrence, or those with rheumatic fever history 1

Important Diagnostic Caveats

  • Behavioral changes like screaming, crying, and tantrums alone are too nonspecific and could represent normal developmental variation 2
  • PANDAS should be distinguished from Sydenham chorea, which is a major manifestation of rheumatic fever and shares similar autoimmune mechanisms 3

Treatment Recommendations

First-Line Treatment: Antibiotics

When PANDAS is suspected with confirmed or likely streptococcal infection, the initial treatment is antibiotics to eradicate the infection 1, 3:

Preferred antibiotic regimens:

  • Penicillin V: 500 mg four times daily for 10 days 1, 3
  • Amoxicillin: 500 mg three times daily for 10 days (or 50 mg/kg once daily, maximum 1000 mg, for children) 1, 2, 3

For penicillin-allergic patients:

  • Erythromycin 1, 3
  • Azithromycin: maximum 500 mg once daily for 3-5 days 1, 3
  • Clindamycin: 300 mg four times daily for 10 days, especially for eradication failures 1, 3

For treatment failures:

  • Consider alternative antibiotics: clindamycin, narrow-spectrum cephalosporins, or amoxicillin-clavulanic acid 1
  • Consider combination therapy with penicillin plus rifampin 1
  • Intramuscular benzathine penicillin G for patients unlikely to complete oral therapy 1

What NOT to Do

The American Heart Association explicitly recommends against:

  • Long-term antistreptococcal prophylaxis to prevent PANDAS 1, 2, 3
  • Immunoregulatory therapy (intravenous immunoglobulin, plasma exchange) as first-line treatment 1, 2, 3
  • Tonsillectomy or adenotonsillectomy does not improve neuropsychiatric course, antibody titers, or symptom severity 6

Evidence Quality and Controversy

A critical caveat: rigorously conducted research on PANDAS treatments is scarce, and published studies have high risk of bias 8. The systematic review evidence reveals:

  • The evidence base for PANDAS treatment consists primarily of case reports and small studies with methodological limitations 8
  • The American Heart Association's position that PANDAS remains "an unproven hypothesis" reflects the lack of definitive evidence for the autoimmune mechanism 1, 2, 3

Long-Term Considerations

Even after resolution of acute symptoms, patients may experience persistent difficulties:

  • Relative impairments in executive functions (attentional regulation, inhibitory control, processing speed) 5
  • Reduced graphomotor skills and academic fluency (reading and math) despite normal core academic abilities 5
  • Ongoing anxiety, depression, inattention, and social skills difficulties requiring clinical intervention 5
  • The majority of patients may require special education services or accommodations 5

References

Guideline

Initial Treatment for PANDAS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

PANS/PANDAS Diagnostic Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

PANDAS Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of PANDAS and PANS: a systematic review.

Neuroscience and biobehavioral reviews, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.